IE 11 is not supported. For an optimal experience visit our site on another browser.

FDA pauses Johnson & Johnson vaccine rollout after cases of rare blood clots 


The FDA has announced a pause in distribution of the Johnson & Johnson Covid-19 vaccine as six women developed rare blood clots after receiving the shot. In a statement, Johnson & Johnson said “no clear causal relationship has been established” between rare blood clots and the vaccine.